NICE rejects Ipsen’s cabometyx as treatment for renal cancer on NHS

09:42 EDT 6 Jun 2018 | Pharmaceutical Technology

The UK’s special health authority the National Institute of Health and Care Excellence (NICE) has refused the use of Ipsen’s...
Read More...

The post NICE rejects Ipsen’s cabometyx as treatment for renal cancer on NHS appeared first on Pharmaceutical Technology.

Original Article: NICE rejects Ipsen’s cabometyx as treatment for renal cancer on NHS

More From BioPortfolio on "NICE rejects Ipsen’s cabometyx as treatment for renal cancer on NHS"